Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer

Wen Wei Chang, Fang Wei Hu, Cheng Chia Yu, Hsiu Huan Wang, Hsiang Pu Feng, Chih Lan, Lo Lin Tsai, Yu Chao Chang

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background Previously, we enriched a subpopulation of head and neck cancer-derived tumor initiating cells (HNC-TICs) presented high tumorigenic, chemo-radioresistant, and coupled with epithelial-mesenchymal transition (EMT) properties. The purpose of this study was to investigate the therapeutic effect and molecular mechanisms of quercetin on HNC-TICs. Method ALDH1 activity of head and neck cancer cells with quercetin treatment was assessed by the Aldefluor assay flow cytometry analysis. Self-renewal, invasiveness, and EMT capability of HNC-TICs with different doses of quercetin was presented. Results We first observed that the treatment of quercetin significantly downregulated the ALDH1 activity of head and neck cancer cells in a dose-dependent manner (p <.05). Moreover, quercetin reduced self-renewal property and stemness signatures expression in head and neck cancer-derived sphere cells. The migration ability of head and neck cancer-derived sphere cells was lessened under quercetin treatment partially due to the decreased productions of Twist, N-cadherin, and vimentin. Conclusion Quercetin suppressing HNC-TICs characteristics may therefore be valuable therapeutics clinically in combination with standard treatment modalities.

Original languageEnglish
Pages (from-to)413-419
Number of pages7
JournalHead and Neck
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 2013
Externally publishedYes

Fingerprint

Quercetin
Head and Neck Neoplasms
Neoplastic Stem Cells
Neoplasms
Epithelial-Mesenchymal Transition
Therapeutic Uses
Vimentin
Cadherins
Flow Cytometry
Down-Regulation

Keywords

  • epithelial-mesenchymal transition
  • head and neck cancer
  • metastasis
  • quercetin
  • tumor initiating cells

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Chang, W. W., Hu, F. W., Yu, C. C., Wang, H. H., Feng, H. P., Lan, C., ... Chang, Y. C. (2013). Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer. Head and Neck, 35(3), 413-419. https://doi.org/10.1002/hed.22982

Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer. / Chang, Wen Wei; Hu, Fang Wei; Yu, Cheng Chia; Wang, Hsiu Huan; Feng, Hsiang Pu; Lan, Chih; Tsai, Lo Lin; Chang, Yu Chao.

In: Head and Neck, Vol. 35, No. 3, 03.2013, p. 413-419.

Research output: Contribution to journalArticle

Chang, Wen Wei ; Hu, Fang Wei ; Yu, Cheng Chia ; Wang, Hsiu Huan ; Feng, Hsiang Pu ; Lan, Chih ; Tsai, Lo Lin ; Chang, Yu Chao. / Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer. In: Head and Neck. 2013 ; Vol. 35, No. 3. pp. 413-419.
@article{7677e158ec0441a79c544e7a8bab2dcc,
title = "Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer",
abstract = "Background Previously, we enriched a subpopulation of head and neck cancer-derived tumor initiating cells (HNC-TICs) presented high tumorigenic, chemo-radioresistant, and coupled with epithelial-mesenchymal transition (EMT) properties. The purpose of this study was to investigate the therapeutic effect and molecular mechanisms of quercetin on HNC-TICs. Method ALDH1 activity of head and neck cancer cells with quercetin treatment was assessed by the Aldefluor assay flow cytometry analysis. Self-renewal, invasiveness, and EMT capability of HNC-TICs with different doses of quercetin was presented. Results We first observed that the treatment of quercetin significantly downregulated the ALDH1 activity of head and neck cancer cells in a dose-dependent manner (p <.05). Moreover, quercetin reduced self-renewal property and stemness signatures expression in head and neck cancer-derived sphere cells. The migration ability of head and neck cancer-derived sphere cells was lessened under quercetin treatment partially due to the decreased productions of Twist, N-cadherin, and vimentin. Conclusion Quercetin suppressing HNC-TICs characteristics may therefore be valuable therapeutics clinically in combination with standard treatment modalities.",
keywords = "epithelial-mesenchymal transition, head and neck cancer, metastasis, quercetin, tumor initiating cells",
author = "Chang, {Wen Wei} and Hu, {Fang Wei} and Yu, {Cheng Chia} and Wang, {Hsiu Huan} and Feng, {Hsiang Pu} and Chih Lan and Tsai, {Lo Lin} and Chang, {Yu Chao}",
year = "2013",
month = "3",
doi = "10.1002/hed.22982",
language = "English",
volume = "35",
pages = "413--419",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer

AU - Chang, Wen Wei

AU - Hu, Fang Wei

AU - Yu, Cheng Chia

AU - Wang, Hsiu Huan

AU - Feng, Hsiang Pu

AU - Lan, Chih

AU - Tsai, Lo Lin

AU - Chang, Yu Chao

PY - 2013/3

Y1 - 2013/3

N2 - Background Previously, we enriched a subpopulation of head and neck cancer-derived tumor initiating cells (HNC-TICs) presented high tumorigenic, chemo-radioresistant, and coupled with epithelial-mesenchymal transition (EMT) properties. The purpose of this study was to investigate the therapeutic effect and molecular mechanisms of quercetin on HNC-TICs. Method ALDH1 activity of head and neck cancer cells with quercetin treatment was assessed by the Aldefluor assay flow cytometry analysis. Self-renewal, invasiveness, and EMT capability of HNC-TICs with different doses of quercetin was presented. Results We first observed that the treatment of quercetin significantly downregulated the ALDH1 activity of head and neck cancer cells in a dose-dependent manner (p <.05). Moreover, quercetin reduced self-renewal property and stemness signatures expression in head and neck cancer-derived sphere cells. The migration ability of head and neck cancer-derived sphere cells was lessened under quercetin treatment partially due to the decreased productions of Twist, N-cadherin, and vimentin. Conclusion Quercetin suppressing HNC-TICs characteristics may therefore be valuable therapeutics clinically in combination with standard treatment modalities.

AB - Background Previously, we enriched a subpopulation of head and neck cancer-derived tumor initiating cells (HNC-TICs) presented high tumorigenic, chemo-radioresistant, and coupled with epithelial-mesenchymal transition (EMT) properties. The purpose of this study was to investigate the therapeutic effect and molecular mechanisms of quercetin on HNC-TICs. Method ALDH1 activity of head and neck cancer cells with quercetin treatment was assessed by the Aldefluor assay flow cytometry analysis. Self-renewal, invasiveness, and EMT capability of HNC-TICs with different doses of quercetin was presented. Results We first observed that the treatment of quercetin significantly downregulated the ALDH1 activity of head and neck cancer cells in a dose-dependent manner (p <.05). Moreover, quercetin reduced self-renewal property and stemness signatures expression in head and neck cancer-derived sphere cells. The migration ability of head and neck cancer-derived sphere cells was lessened under quercetin treatment partially due to the decreased productions of Twist, N-cadherin, and vimentin. Conclusion Quercetin suppressing HNC-TICs characteristics may therefore be valuable therapeutics clinically in combination with standard treatment modalities.

KW - epithelial-mesenchymal transition

KW - head and neck cancer

KW - metastasis

KW - quercetin

KW - tumor initiating cells

UR - http://www.scopus.com/inward/record.url?scp=84874108284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874108284&partnerID=8YFLogxK

U2 - 10.1002/hed.22982

DO - 10.1002/hed.22982

M3 - Article

C2 - 22422628

AN - SCOPUS:84874108284

VL - 35

SP - 413

EP - 419

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 3

ER -